LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Letter by Adabag et al Regarding Article, "Age and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Systolic Heart Failure".

Photo from wikipedia

Elming et al1 report that the efficacy of primary prevention implantable cardioverter-defibrillator (ICD) therapy is diminished among older participants of the DANISH trial (Danish Study to Assess the Efficacy of… Click to show full abstract

Elming et al1 report that the efficacy of primary prevention implantable cardioverter-defibrillator (ICD) therapy is diminished among older participants of the DANISH trial (Danish Study to Assess the Efficacy of ICDs in Patients With Nonischemic Systolic Heart Failure on Mortality), which randomized patients with nonischemic cardiomyopathy to ICD versus optimal medical therapy.2 In this secondary data analysis of the DANISH trial, ICD implantation was associated with a statistically significant improvement in survival among patients ≤70 years of age but not in those >70 years of age. This area of study is important because …

Keywords: age; patients nonischemic; prevention implantable; nonischemic systolic; primary prevention; implantable cardioverter

Journal Title: Circulation
Year Published: 2018

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.